OverviewSuggest Edit

TearLab is an in-vitro diagnostic company, which develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. TearLab offers TearLab Osmolority System, which is intended to measure the osmolarity of human tears to aid in the diagnosis of dry eye disease in patients suspected of having dry eye disease, in conjunction with other methods of clinical evaluation.

TypePublic
Founded2003
HQEscondido, US
Websitetearlab.com
Employee Ratings2.9

Latest Updates

Employees (est.) (Dec 2019)39(+15%)
Job Openings1
Revenue (FY, 2019)$22.7 M(-9%)
Share Price (Jul 2020)$0.1
Cybersecurity ratingAMore

Key People/Management at TearLab

Michael Berg

Michael Berg

Vice President of Regulatory
Seph Jensen

Seph Jensen

Chief Executive Officer
Sam Fakhoury

Sam Fakhoury

Vice President of Quality, Compliance and Supply Chain
Benjamin Sullivan

Benjamin Sullivan

Chief Scientific Officer
Michael Marquez

Michael Marquez

Chief Financial Officer
Steve Zmina

Steve Zmina

Vice President of Manufacturing & Engineering
Show more

TearLab Office Locations

TearLab has an office in Escondido
Escondido, US (HQ)
800 La Terraza Blvd Suite 101
Show all (1)

TearLab Financials and Metrics

TearLab Revenue

TearLab's revenue was reported to be $22.66 m in FY, 2019
USD

Revenue (Q1, 2020)

5.1m

Net income (Q1, 2020)

(1.6m)

EBIT (Q1, 2020)

(140.0k)

Market capitalization (13-Jul-2020)

1.4m

Closing stock price (13-Jul-2020)

0.1

Cash (31-Mar-2020)

7.3m

EV

70.7m
TearLab's current market capitalization is $1.4 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

2.1m4.0m14.6m19.7m25.2m28.0m27.1m25.0m22.7m

Revenue growth, %

35%28%11%

Cost of goods sold

1.6m2.3m8.1m8.8m10.8m10.2m11.0m

Gross profit

498.0k1.7m6.5m10.9m14.3m17.8m16.1m
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Revenue

468.0k333.0k422.0k716.0k1.2m2.5m3.5m4.2m4.2m5.0m5.2m5.4m6.3m6.6m6.8m6.9m7.2m6.7m7.0m6.5m6.4m6.4m6.2m5.7m5.9m5.6m5.1m

Cost of goods sold

276.0k529.0k331.0k341.0k692.0k1.4m2.1m2.3m2.2m2.5m2.7m2.4m2.8m2.8m2.5m2.5m2.6m2.5m2.7m3.0m1.8m2.4m2.2m

Gross profit

192.0k(196.0k)91.0k375.0k519.0k1.1m1.4m1.9m2.0m2.5m2.5m3.0m3.5m3.8m4.2m4.4m4.7m4.2m4.3m3.5m4.6m4.1m4.0m

Gross profit Margin, %

41%(59%)22%52%43%43%40%46%48%51%48%56%56%57%62%64%65%62%62%54%72%63%65%
USDQ2, 2011

Financial Leverage

2 x
Show all financial metrics

TearLab Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

TearLab Online and Social Media Presence

Embed Graph

TearLab News and Updates

TearLab Corporation Reports Fourth Quarter and Full Year 2018 Financial Results

ESCONDIDO, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and twelve months ended December 31, 2018. All dollar amounts are expressed in U.S. currency and results are …

TearLab Corporation Reports Third Quarter 2018 Financial Results

ESCONDIDO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter ended September 30, 2018. All dollar amounts are expressed in U.S. currency and results are reported in accord…

TearLab Update on 510(k) for U.S. FDA Clearance of Discovery™ MMP-9 Test

SAN DIEGO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has determined that the TearLab Discovery™ MMP-9 test, has not met the criteria for substantial equivalence based upon data …

TearLab Frequently Asked Questions

  • When was TearLab founded?

    TearLab was founded in 2003.

  • Who are TearLab key executives?

    TearLab's key executives are Michael Berg, Seph Jensen and Sam Fakhoury.

  • How many employees does TearLab have?

    TearLab has 39 employees.

  • What is TearLab revenue?

    Latest TearLab annual revenue is $22.7 m.

  • What is TearLab revenue per employee?

    Latest TearLab revenue per employee is $580.9 k.

  • Who are TearLab competitors?

    Competitors of TearLab include Kallo, Non-Invasive Monitoring Systems and Atlantic Therapeutics.

  • Where is TearLab headquarters?

    TearLab headquarters is located at 800 La Terraza Blvd Suite 101, Escondido.

  • Where are TearLab offices?

    TearLab has an office in Escondido.

  • How many offices does TearLab have?

    TearLab has 1 office.